Business Daily Media

Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

  • Written by PR Newswire

- First approved allogeneic cell therapy product globally for the treatment of CLI

- Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost

- Cipla to market and distribute the drug in India to provide patient access

Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

MUMBAI, India, Aug. 21, 2020 /PRNewswire/...

A Beginner’s Guide to Selling Your Mortgage Note

If you currently hold a mortgage note and want to unlock its value, selling it on the secondary market could be worth exploring. The secondary mortg...

Property

Former Etihad boss brings substantial event insight to PMY Group Board

Paul Sergeant PMY Group, the architects of the digital insurgency occurring at major venues across Australia and New Zealand, are delighted to ...

Business Training

The 5 Tell-Tale Signs Of a Toxic Workplace

Wearing a mask wears you out. Faking it is fatiguing. The most exhausting activity is pretending to be what you know you aren’t. – Rick Warren ...

Business Training

Balancing Entrepreneurship and Parenting: How to become a successful Dad-preneur

Juggling parenting and family life, whilst running a successful business and maintaining work-life balance is no easy feat! To invest in you...

Business Training

Why Pinterest Should Be Part of Your Marketing Strategy

Pinterest is a growing social media platform that can deliver significant traffic to your website and new followers to your brand. With it’s steady gr...

Business Training

5 Steps for Creating Effective Solutions to UX Problems

One of the most important components of any website or app is the design of the user experience (UX). Even the smallest UX issues need to be ident...

Business Training